Jianjun Luo

1.6k total citations
88 papers, 1.1k citations indexed

About

Jianjun Luo is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Jianjun Luo has authored 88 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hepatology, 41 papers in Surgery and 31 papers in Epidemiology. Recurrent topics in Jianjun Luo's work include Liver Disease and Transplantation (34 papers), Hepatocellular Carcinoma Treatment and Prognosis (34 papers) and Liver Disease Diagnosis and Treatment (29 papers). Jianjun Luo is often cited by papers focused on Liver Disease and Transplantation (34 papers), Hepatocellular Carcinoma Treatment and Prognosis (34 papers) and Liver Disease Diagnosis and Treatment (29 papers). Jianjun Luo collaborates with scholars based in China, United States and Nepal. Jianjun Luo's co-authors include Zhiping Yan, Qingxin Liu, Jianhua Wang, Yi Chen, Xiaolin Wang, Minjie Yang, Zhi-Ping Yan, Jingqin Ma, Wen Zhang and Jianhua Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jianjun Luo

78 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianjun Luo China 19 576 405 353 263 173 88 1.1k
Gregory M. Tiao United States 22 373 0.6× 601 1.5× 152 0.4× 264 1.0× 130 0.8× 59 1.2k
Douglas Quan Canada 25 658 1.1× 738 1.8× 227 0.6× 155 0.6× 99 0.6× 64 1.5k
Yun Soo Kim South Korea 19 429 0.7× 545 1.3× 376 1.1× 401 1.5× 81 0.5× 73 1.1k
Hikaru Fujioka Japan 20 436 0.8× 579 1.4× 211 0.6× 184 0.7× 72 0.4× 67 1.0k
Raphael Mohr Germany 18 290 0.5× 176 0.4× 311 0.9× 233 0.9× 131 0.8× 70 942
Sun Young Yim South Korea 18 472 0.8× 160 0.4× 457 1.3× 95 0.4× 176 1.0× 74 977
Long‐Bin Jeng Taiwan 20 390 0.7× 423 1.0× 295 0.8× 181 0.7× 128 0.7× 61 1.1k
Kun‐Ming Chan Taiwan 26 1.1k 1.9× 899 2.2× 551 1.6× 280 1.1× 179 1.0× 118 1.8k
Chih‐Yun Lin Taiwan 13 673 1.2× 265 0.7× 491 1.4× 121 0.5× 193 1.1× 33 965
Tobias J. Weismüller Germany 19 670 1.2× 867 2.1× 415 1.2× 396 1.5× 60 0.3× 65 1.4k

Countries citing papers authored by Jianjun Luo

Since Specialization
Citations

This map shows the geographic impact of Jianjun Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Luo more than expected).

Fields of papers citing papers by Jianjun Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Luo. The network helps show where Jianjun Luo may publish in the future.

Co-authorship network of co-authors of Jianjun Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Luo. A scholar is included among the top collaborators of Jianjun Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Luo. Jianjun Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Mingyan, Shikun Xie, Shuo Wu, et al.. (2025). A novel perspective of ATR-FTIR spectroscopy combined with multiple machine learning methods for postmortem interval (PMI) human skin. Vibrational Spectroscopy. 138. 103800–103800. 1 indexed citations
2.
Liu, Yaozu, Jingqin Ma, Yongjie Zhou, et al.. (2024). Unveiling the impact of cirrhotic cardiomyopathy on portal hemodynamics and survival after transjugular intrahepatic portosystemic shunt: a prospective study. Abdominal Radiology. 49(10). 3507–3516. 2 indexed citations
3.
Shi, Qin, Wen Zhang, Yongjie Zhou, et al.. (2024). Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinoma. Biomaterials. 306. 122480–122480. 19 indexed citations
5.
Zhou, Yongjie, Tianzhu Yu, Wen Zhang, et al.. (2023). Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction. Thrombosis Journal. 21(1). 6–6. 2 indexed citations
6.
Liu, Yaozu, Jingqin Ma, Ximing Gong, & Jianjun Luo. (2023). A Rare Cause of Chronic Intermittent Hematochezia. The American Journal of Medicine. 137(3). e54–e55. 1 indexed citations
7.
Tseng, Yujen, et al.. (2020). Application of CT-based radiomics in predicting portal pressure and patient outcome in portal hypertension. European Journal of Radiology. 126. 108927–108927. 15 indexed citations
8.
Wu, Linlin, Yanbo Zhang, Zihan Zhang, Fengfeng Li, & Jianjun Luo. (2020). Endovascular implantation of iodine-125 seed strandcombined and stent placement for locally advancedpancreatic ductal adenocarcinoma with vascularinvasion: a prospective single-arm pilot study. Journal of Contemporary Brachytherapy. 12(5). 427–434. 2 indexed citations
9.
Ma, Jingqin, Jianjun Luo, Qingxin Liu, et al.. (2019). The Efficacy and Safety of Transcatheter Arterial Embolization to Treat Renal Hemorrhage after Percutaneous Nephrolithotomy. BioMed Research International. 2019. 1–10. 22 indexed citations
10.
Yang, Minjie, Jingqin Ma, Jianjun Luo, et al.. (2019). Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access. Translational Cancer Research. 8(5). 1795–1805. 2 indexed citations
11.
Kong, Wentao, Yu Gan, Ning‐lin Ge, et al.. (2019). Tumour stiffness associated with tumour response to conventional transarterial chemoembolisation for hepatocellular carcinoma: preliminary findings. Clinical Radiology. 74(10). 814.e1–814.e7. 3 indexed citations
12.
Tang, Hanfei, Xiao Tang, Weiguo Fu, et al.. (2018). Coil embolization of renal artery bifurcation and branch aneurysms with flow preservation. Journal of Vascular Surgery. 68(2). 451–458.e2. 15 indexed citations
13.
Zhang, Zi‐Han, Qingxin Liu, Wen Zhang, et al.. (2017). Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. World Journal of Gastroenterology. 23(43). 7735–7745. 22 indexed citations
14.
Guo, Baolei, Daqiao Guo, Xin Xu, et al.. (2016). Early and intermediate results of endovascular treatment of symptomatic and asymptomatic visceral artery aneurysms. Journal of Vascular Surgery. 64(1). 140–148. 22 indexed citations
15.
Li, Wenhui, et al.. (2015). Chemoembolization and stenting combined with iodine-125 seed strands for the treatment of hepatocellular carcinoma with inferior vena cava obstruction. Experimental and Therapeutic Medicine. 10(3). 973–977. 5 indexed citations
16.
Qu, Xu-Dong, Chengshi Chen, Jianhua Wang, et al.. (2012). The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma. BMC Cancer. 12(1). 263–263. 79 indexed citations
18.
Chen, Yi, Xiaolin Wang, Jianhua Wang, Zhiping Yan, & Jianjun Luo. (2012). Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies. European Journal of Cancer. 48(14). 2137–2145. 192 indexed citations
19.
Chen, Yi, Xiaolin Wang, Zhiping Yan, et al.. (2011). The Use of 125 I Seed Strands for Intraluminal Brachytherapy of Malignant Obstructive Jaundice. Cancer Biotherapy and Radiopharmaceuticals. 27(5). 317–323. 40 indexed citations
20.
Luo, Jianjun. (2010). The Therapeutic Value of Percutaneous Portal Vein Thrombolysis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026